Cargando…

Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort

BACKGROUND: Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine whether MBL levels differ between patients with an acute myocardial infarction (MI) and he...

Descripción completa

Detalles Bibliográficos
Autores principales: Meziani, Sara, Ferrannini, Giulia, Bjerre, Mette, Hansen, Troels K., Ritsinger, Viveca, Norhammar, Anna, Gyberg, Viveca, Näsman, Per, Rydén, Lars, Mellbin, Linda G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270763/
https://www.ncbi.nlm.nih.gov/pubmed/35804351
http://dx.doi.org/10.1186/s12933-022-01562-0
_version_ 1784744536451317760
author Meziani, Sara
Ferrannini, Giulia
Bjerre, Mette
Hansen, Troels K.
Ritsinger, Viveca
Norhammar, Anna
Gyberg, Viveca
Näsman, Per
Rydén, Lars
Mellbin, Linda G.
author_facet Meziani, Sara
Ferrannini, Giulia
Bjerre, Mette
Hansen, Troels K.
Ritsinger, Viveca
Norhammar, Anna
Gyberg, Viveca
Näsman, Per
Rydén, Lars
Mellbin, Linda G.
author_sort Meziani, Sara
collection PubMed
description BACKGROUND: Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine whether MBL levels differ between patients with an acute myocardial infarction (MI) and healthy controls and between subgroups with different glucose tolerance status, and (ii) to investigate the relation between MBL and future cardiovascular events. METHODS: MBL levels were assessed at discharge and after 3 months in 161 AMI patients without any previously known glucose perturbations and in 183 age- and gender-matched controls from the Glucose metabolism in patients with Acute Myocardial Infarction (GAMI) study. Participants were classified as having dysglycaemia, i.e. type 2 diabetes or impaired glucose tolerance, or not by an oral glucose tolerance test. The primary outcome was a composite of cardiovascular events comprising cardiovascular death, AMI, stroke or severe heart failure during 11 years of follow-up. Total and cardiovascular mortality served as secondary outcomes. RESULTS: At hospital discharge patients had higher MBL levels (median 1246 μg/L) than three months later (median 575 μg/L; p < 0.01), the latter did not significantly differ from those in the controls (801 μg/L; p = 0.47). MBL levels were not affected by dysglycaemia either in patients or controls. Independent of glycaemic state, increasing MBL levels did not predict any of the studied outcomes in patients. In unadjusted analyses increasing MBL levels predicted cardiovascular events (hazard ratio HR: 1.67, 95% confidence interval CI 1.06–2.64) and total mortality (HR 1.53, 95% CI 1.12–2.10) in the control group. However, this did not remain in adjusted analyses. CONCLUSIONS: Patients had higher MBL levels than controls during the hospital phase of AMI, supporting the assumption that elevated MBL reflects acute stress. MBL was not found to be independently associated with cardiovascular prognosis in patients with AMI regardless of glucose state. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01562-0.
format Online
Article
Text
id pubmed-9270763
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92707632022-07-10 Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort Meziani, Sara Ferrannini, Giulia Bjerre, Mette Hansen, Troels K. Ritsinger, Viveca Norhammar, Anna Gyberg, Viveca Näsman, Per Rydén, Lars Mellbin, Linda G. Cardiovasc Diabetol Research BACKGROUND: Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine whether MBL levels differ between patients with an acute myocardial infarction (MI) and healthy controls and between subgroups with different glucose tolerance status, and (ii) to investigate the relation between MBL and future cardiovascular events. METHODS: MBL levels were assessed at discharge and after 3 months in 161 AMI patients without any previously known glucose perturbations and in 183 age- and gender-matched controls from the Glucose metabolism in patients with Acute Myocardial Infarction (GAMI) study. Participants were classified as having dysglycaemia, i.e. type 2 diabetes or impaired glucose tolerance, or not by an oral glucose tolerance test. The primary outcome was a composite of cardiovascular events comprising cardiovascular death, AMI, stroke or severe heart failure during 11 years of follow-up. Total and cardiovascular mortality served as secondary outcomes. RESULTS: At hospital discharge patients had higher MBL levels (median 1246 μg/L) than three months later (median 575 μg/L; p < 0.01), the latter did not significantly differ from those in the controls (801 μg/L; p = 0.47). MBL levels were not affected by dysglycaemia either in patients or controls. Independent of glycaemic state, increasing MBL levels did not predict any of the studied outcomes in patients. In unadjusted analyses increasing MBL levels predicted cardiovascular events (hazard ratio HR: 1.67, 95% confidence interval CI 1.06–2.64) and total mortality (HR 1.53, 95% CI 1.12–2.10) in the control group. However, this did not remain in adjusted analyses. CONCLUSIONS: Patients had higher MBL levels than controls during the hospital phase of AMI, supporting the assumption that elevated MBL reflects acute stress. MBL was not found to be independently associated with cardiovascular prognosis in patients with AMI regardless of glucose state. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01562-0. BioMed Central 2022-07-08 /pmc/articles/PMC9270763/ /pubmed/35804351 http://dx.doi.org/10.1186/s12933-022-01562-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Meziani, Sara
Ferrannini, Giulia
Bjerre, Mette
Hansen, Troels K.
Ritsinger, Viveca
Norhammar, Anna
Gyberg, Viveca
Näsman, Per
Rydén, Lars
Mellbin, Linda G.
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
title Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
title_full Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
title_fullStr Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
title_full_unstemmed Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
title_short Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
title_sort mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. a report from the gami cohort
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270763/
https://www.ncbi.nlm.nih.gov/pubmed/35804351
http://dx.doi.org/10.1186/s12933-022-01562-0
work_keys_str_mv AT mezianisara mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort
AT ferranninigiulia mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort
AT bjerremette mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort
AT hansentroelsk mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort
AT ritsingerviveca mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort
AT norhammaranna mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort
AT gybergviveca mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort
AT nasmanper mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort
AT rydenlars mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort
AT mellbinlindag mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort